Geneva, May 18 -- International Clinical Trials Registry received information related to the study (ChiCTR2600124206) titled 'A phase II clinical study of adjuvant immunotherapy with or without chemotherapy in NSCLC patients who did not achieve pCR after neoadjuvant chemoimmunotherapy and surgery' on May 8.
Study Type: Interventional study
Study Design:
Cohort study
Primary Sponsor: Chengdu Seventh People's Hospital
Condition:
Non-small cell lung cancer
Intervention:
Cohort 1:Toripalimab combined with platinum?based doublet chemotherapy for 2-3 cycles, followed by toripalimab alone for 11-12 cycles.
Recruitment Status: Not Recruiting
Phase: 2
Date of First Enrollment: 2026-05-10
Target Sample Size: Cohort 1:50;Cohort 2:50; ...